MTOR and tuberous sclerosis: In the context of TSC-related epilepsy, the use of mTOR inhibitor drugs, such as everolimus, represents a possibility for a treatment for refractory epilepsy, targeting the genetic cause.5, 11Thus, this systematic review aims to evaluate the efficacy of everolimus in controlling refractory epilepsy in pediatric patients with tuberous sclerosis.